301 BINNEY STREET, CAMBRIDGE, MA
Other Events
FDA Issues CRL for Apitegromab Treatment for SMA
Investor Presentation
Changing the Company's Accountant
Shareholder votes
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Correspondence
Submission Upload